Androgen deprivation by activating the liver X receptor.
about
Blockade of islet amyloid polypeptide fibrillation and cytotoxicity by the secretory chaperones 7B2 and proSAASRegulation of the cytosolic sulfotransferases by nuclear receptorsThe neuroendocrine protein 7B2 suppresses the aggregation of neurodegenerative disease-related proteinsAlzPlatform: an Alzheimer's disease domain-specific chemogenomics knowledgebase for polypharmacology and target identification research.Minireview: Nuclear receptor-controlled steroid hormone synthesis and metabolismSulfotransferase genes: regulation by nuclear receptors in response to xeno/endo-biotics.A novel role for the dioxin receptor in fatty acid metabolism and hepatic steatosisTranscriptional regulation of human hydroxysteroid sulfotransferase SULT2A1 by LXRα.A functional cross-talk between liver X receptor-α and constitutive androstane receptor links lipogenesis and xenobiotic responses.Regulation of the human hydroxysteroid sulfotransferase (SULT2A1) by RORα and RORγ and its potential relevance to human liver diseases.Pregnane X receptor as a therapeutic target to inhibit androgen activity.MicroRNA hsa-miR-613 targets the human LXRα gene and mediates a feedback loop of LXRα autoregulation.Liver x receptors protect from development of prostatic intra-epithelial neoplasia in mice.The pituitary gland of the European eel reveals massive expression of genes involved in the melanocortin systemDynamic modulation of prohormone convertase 2 (PC2)-mediated precursor processing by 7B2 protein: preferential effect on glucagon synthesisChanges of Cerebrospinal Fluid Peptides due to Tauopathy.Liver X receptor alpha mediated genistein induction of human dehydroepiandrosterone sulfotransferase (hSULT2A1) in Hep G2 cells.SULT2B1b sulfotransferase: induction by vitamin D receptor and reduced expression in prostate cancer.Distinct gene regulatory programs define the inhibitory effects of liver X receptors and PPARG on cancer cell proliferationThe constitutive androstane receptor is an anti-obesity nuclear receptor that improves insulin sensitivity.Site-specific cleavage of BMP4 by furin, PC6, and PC7.Cooperative behavior of the nuclear receptor superfamily and its deregulation in prostate cancer.Cholesterol sulfate and cholesterol sulfotransferase inhibit gluconeogenesis by targeting hepatocyte nuclear factor 4α.A novel function for proSAAS as an amyloid anti-aggregant in Alzheimer's disease.LXR, prostate cancer and cholesterol: the Good, the Bad and the Ugly.The emerging roles of liver X receptors and their ligands in cancer.The Contribution of Cholesterol and Its Metabolites to the Pathophysiology of Breast CancerCholesterol Sulfonation Enzyme, SULT2B1b, Modulates AR and Cell Growth Properties in Prostate Cancer.Cross-talk between the androgen receptor and the liver X receptor: implications for cholesterol homeostasis.Liver X receptor alpha (LXRalpha) as a therapeutic target in chronic lymphocytic leukemia (CLL).Regulation of Cholesterol Sulfotransferase SULT2B1b by HNF4α Constitutes a Negative Feedback Control of Hepatic Gluconeogenesis.Secretogranin III: a diabetic retinopathy-selective angiogenic factor.New Insights in Prostate Cancer Development and Tumor Therapy: Modulation of Nuclear Receptors and the Specific Role of Liver X Receptors
P2860
Q24336425-C43C7EA9-75BA-4FBB-9387-83037CCAC44FQ26997383-FDA706C9-D090-4C6D-875B-202800276D0BQ28279676-38A7518C-FAD5-433B-911C-E88DD11FD887Q33567120-B9692919-3F4E-41FD-B628-A86F3C4E17C0Q33579464-DDD3EA73-0D31-4DB6-9A82-C7F4221E6B95Q33726321-0AE1357D-B0DE-458D-95B4-454E19379F24Q34023100-6F28ADFA-D347-4E17-98B8-F27417911050Q34185996-A09D6F95-B766-48F1-B673-369A4EA71932Q34310040-63B939D4-297C-48B6-AABC-282F98E036A6Q34315555-8A17188D-28AE-4D12-95F1-4E3782AA8704Q34392652-F837FA0A-5A24-4CD3-806E-8465FB00E348Q34712126-C81E4374-1EEC-4376-AAC1-42AA3D65BF18Q34722551-415F7269-A9BD-4F12-8791-09569615CAB6Q35018852-9FE63EB9-AD9A-4771-8FAB-4DF5B371380FQ35604923-61CB5374-3F27-40C8-817C-E246EFF01A6AQ36357894-5C3F883A-D175-42D2-AE05-C2D3A2153295Q36704213-7BF081E6-0EBE-4FF1-8C1A-75F4F9B5FCF8Q36850145-05F62861-EA2E-43B6-AF51-8BB5DA8E99A2Q37084995-244BA9F2-146D-4E73-9488-4C23BEA10FEBQ37377724-70CEC49E-A89B-4145-BF49-41DF065FFF1BQ37447929-ED04A792-3E66-4BE1-A319-6A4303C23CC4Q37537548-BC21AA6E-36CF-4736-B465-AA8A80993CF4Q37546947-208F8C0E-D226-470F-AD4B-56C82BA781BCQ37625372-686CDAD6-34DE-4348-A0A2-A6E27257F2EBQ38077536-A8632DFB-D0A4-430A-B197-A7FEC63C50C7Q38703765-35077996-7994-4D4D-B09C-F485A95584EBQ38791223-476E7C97-A4B5-4F13-BD7E-E5DACC103A35Q39656931-4EF3352A-6B79-4AD2-9CED-AF37A9ED7EFDQ41989015-7A8C8F96-8BD1-40FA-85E9-2161C5ADEF3DQ42625569-0440718F-BF2B-4815-8F6B-CD8D7A15A5B1Q47643617-892D3BE6-0B1D-42F7-8234-D00E83D9A422Q47879810-A5BE31F8-EE47-4872-A7EE-0ACEA45324A4Q57107495-B8F816B9-959F-4C5B-A587-F30094B4855A
P2860
Androgen deprivation by activating the liver X receptor.
description
2008 nî lūn-bûn
@nan
2008 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Androgen deprivation by activating the liver X receptor.
@ast
Androgen deprivation by activating the liver X receptor.
@en
type
label
Androgen deprivation by activating the liver X receptor.
@ast
Androgen deprivation by activating the liver X receptor.
@en
prefLabel
Androgen deprivation by activating the liver X receptor.
@ast
Androgen deprivation by activating the liver X receptor.
@en
P2093
P2860
P356
P1433
P1476
Androgen deprivation by activating the liver X receptor.
@en
P2093
Haibiao Gong
Jian Zhang
Jung Hoon Lee
Shaheen Khadem
P2860
P304
P356
10.1210/EN.2008-0064
P407
P577
2008-05-01T00:00:00Z